High incidence of secondary malignancies after allogeneic haematopoietic stem cell transplantation

被引：0
|
作者：
Neuburger, S. [1 ]
Hemmati, P. [1 ]
Massenkeil, G. [2 ]
Terwey, T. [1 ]
Kim, T. [1 ]
le Coutre, P. [1 ]
Doerken, B. [1 ]
Arnold, R. [1 ]
机构：
[1] Charite Virchow Klinikum, Berlin, Germany
[2] Klinikum Stadt Ludwigshafen, Gutersloh, Germany
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [1] Lung transplantation after allogeneic haematopoietic stem cell transplantation
    Dodds, A.
    Potter, V.
    Bradstock, K.
    O'Brien, T.
    Glanville, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 216 - 216
  • [2] Cidofovir treatment for haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation for high risk haematological malignancies
    Crucitti, L.
    Carrabba, M.
    Marktel, S.
    Assanelli, A.
    Salonia, A.
    Greco, R.
    Vago, L.
    Lorentino, F.
    Stanghellini, M. T. Lupo
    Bernardi, M.
    Corti, C.
    Peccatori, J.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S316 - S317
  • [3] Mucormycosis after allogeneic haematopoietic stem cell transplantation
    Clement, L
    Salmon, A
    Mansuy, L
    Paczesny, S
    Bordigoni, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S205 - S205
  • [4] Incidence of secondary malignancies in recipients of allogeneic stem cell transplantation: a single centre experience
    Sheikh, S. N.
    Danby, R.
    Wong, H.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S431 - S431
  • [5] Haematopoietic reconstitution after autologous and allogeneic haematopoietic stem cell transplantation
    Pugachev, A.
    Mikhaylova, N.
    Golovacheva, A.
    Babenko, E.
    Estrina, M.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S306 - S306
  • [6] Nivolumab for Relapsed or Residual Haematological Malignancies after Allogeneic Haematopoietic Stem Cell Transplantation (NIVALLO)
    Wong, Eric
    Dawson, Emily
    Davis, Joanne
    Koldej, Rachel
    Ludford-Menting, Mandy
    Lansdown, Matthew
    Lambie, Heather
    Szer, Jeffrey
    Grigg, Andrew P.
    Ritchie, David
    BLOOD, 2018, 132
  • [7] Evolution of mixed chimerism after allogeneic haematopoietic stem cell transplantation in patients with haematologic malignancies
    Levrat, E.
    Roosnek, E.
    Mohty, B.
    Bernimoulin, M.
    Nagy-Hulliger, M.
    Tirefort, Y.
    Paiano, S.
    Ozsahin, H.
    Villard, J.
    Passweg, J.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S199 - S199
  • [8] Secondary solid cancers after allogeneic haematopoietic stem cell transplantation in adult recipients
    Atsuta, Y.
    Suzuki, R.
    Yamashita, T.
    Fukuda, T.
    Miyamura, K.
    Taniguchi, S.
    Iida, H.
    Kasai, M.
    Ogawa, H.
    Takahashi, S.
    Kato, K.
    Kawa, K.
    Nagamura-Inoue, T.
    Morishima, Y.
    Sakamaki, H.
    Kodera, Y.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S57 - S58
  • [9] Allogeneic haematopoietic stem cell transplantation after treosulfan/fludarabine conditioning in high-risk patients with haematologic malignancies
    Casper, J
    Knauf, W
    Blau, W
    Volin, L
    Ruutu, T
    Wandt, H
    Schaefer-Eckart, K
    Holowiecki, J
    Giebel, S
    Aschan, J
    Zander, A
    Kroeger, N
    Freund, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S103 - S104
  • [10] Secondary malignancies after stem cell transplantation
    Campos, A
    Costa, NM
    Vaz, CP
    Carvalhais, A
    Roncon, S
    Campilho, F
    Pimentel, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 595S - 595S
12345